NDAORALTABLETPriority Review
Approved
Feb 2018
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
Priority Review
SYMFI LO (efavirenz; lamivudine; tenofovir disoproxil fumarate) by Viatris (2) is fixed-dose combination of antiviral drugs efv, 3tc, and tdf with antiviral activity against hiv-1 [see ]. First approved in 2018.
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SYMFI LO is a fixed-dose combination tablet containing efavirenz, lamivudine, and tenofovir disoproxil fumarate for oral treatment of HIV-1 infection. It combines three antiretroviral agents with complementary mechanisms to suppress viral replication. This regimen is suitable for treatment-naïve and treatment-experienced patients with HIV-1.
$0.135MPart D
PeakPeak lifecycle stage with minimal Part D penetration suggests mature market positioning; small team focus on market maintenance rather than growth expansion.
Mechanism of Action
fixed-dose combination of antiviral drugs EFV, 3TC, and TDF with antiviral activity against HIV-1 [see ].
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SYMFI LO positions you in a mature, stable product with established market presence and minimal clinical development activity. Roles focus on commercial execution, market access, and safety monitoring rather than innovation-driven growth opportunities.
Brand ManagerMedical Science Liaison
Worked on SYMFI LO at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.